Department of Anesthesiology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
J Int Med Res. 2023 Aug;51(8):3000605231187805. doi: 10.1177/03000605231187805.
To evaluate the perioperative administration of dexamethasone to prevent postoperative shivering.
We searched PubMed, Embase, Google Scholar, Web of Science, and Cochrane Library for relevant studies of the administration of dexamethasone to prevent postoperative shivering published through 31 May 2023. The primary outcome was the incidence of postoperative shivering. Secondary outcomes comprised the incidence of postoperative nausea, vomiting, and postoperative nausea and vomiting (PONV). RevMan 5.3 software was used for the data analysis.
We included 12 randomized controlled trials (1276 participants). The results revealed a benefit favoring the perioperative administration of dexamethasone to prevent postoperative shivering (relative risk [RR]: 0.39; 95% confidence interval [CI]: 0.23-0.63), as well as the grade of shivering. The administration of dexamethasone also reduced the incidence of postoperative nausea (RR: 0.54; 95% CI: 0.39-0.73), postoperative vomiting (RR: 0.37; 95% CI: 0.20-0.65), and PONV (RR: 0.50; 95% CI: 0.26-0.95) compared with the control group.
This study indicated that perioperative administration of dexamethasone prevented postoperative shivering and decreased the incidence of other complications.PROSPERO registration number: CRD42020164488.
评估地塞米松预防术后寒战的围手术期应用。
我们检索了 PubMed、Embase、Google Scholar、Web of Science 和 Cochrane Library,以评估截至 2023 年 5 月 31 日发表的地塞米松预防术后寒战的应用相关研究。主要结局为术后寒战的发生率。次要结局包括术后恶心、呕吐和术后恶心呕吐(PONV)的发生率。使用 RevMan 5.3 软件进行数据分析。
我们纳入了 12 项随机对照试验(1276 名参与者)。结果显示,地塞米松围手术期应用有利于预防术后寒战(相对风险 [RR]:0.39;95%置信区间 [CI]:0.23-0.63),以及寒战的严重程度。地塞米松的应用还降低了术后恶心(RR:0.54;95% CI:0.39-0.73)、术后呕吐(RR:0.37;95% CI:0.20-0.65)和 PONV(RR:0.50;95% CI:0.26-0.95)的发生率,与对照组相比。
本研究表明,地塞米松围手术期应用可预防术后寒战,并降低其他并发症的发生率。
PROSPERO 注册号:CRD42020164488。